SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intercept Pharmaceuticals, Inc. – ICPT

[PR Newswire] – NEW YORK, Feb. 25, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Intercept Pharmaceuticals, Inc. (Intercept or the Company) (ICPT). Such investors are advised to contact Robert S. Willoughby at rswil more

View todays social media effects on ICPT

View the latest stocks trending across Twitter. Click to view dashboard

See who Intercept is hiring next, click here to view